Leucotylic acid
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Others |
| Catalog number | BBF-05420 |
| CAS | 5056-37-1 |
| Molecular Weight | 474.72 |
| Molecular Formula | C30H50O4 |
Online Inquiry
Specification
| Synonyms | (3S,3aS,4S,5aR,5bR,7aR,8R,11aR,11bR,13aR,13bR)-4-hydroxy-3-(2-hydroxypropan-2-yl)-5a,5b,8,11a,13b-pentamethylicosahydro-1H-cyclopenta[a]chrysene-8-carboxylic acid; 16β,22-Dihydroxyhopan-23-oic acid; A'-Neogammaceran-23-oic acid, 16,22-dihydroxy-, (4α,16β)-; Leucotylinsaeure |
| IUPAC Name | (3S,3aS,4S,5aR,5bR,7aR,8R,11aR,11bR,13aR,13bR)-4-hydroxy-3-(2-hydroxypropan-2-yl)-5a,5b,8,11a,13b-pentamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysene-8-carboxylic acid |
| Canonical SMILES | CC12CCCC(C1CCC3(C2CCC4C3(CC(C5C4(CCC5C(C)(C)O)C)O)C)C)(C)C(=O)O |
| InChI | InChI=1S/C30H50O4/c1-25(2,34)18-11-15-27(4)22-10-9-21-26(3)13-8-14-28(5,24(32)33)20(26)12-16-29(21,6)30(22,7)17-19(31)23(18)27/h18-23,31,34H,8-17H2,1-7H3,(H,32,33)/t18-,19-,20+,21+,22+,23+,26-,27+,28+,29+,30+/m0/s1 |
| InChI Key | UVMOVHJYWYVSKR-FLPYHIANSA-N |
Properties
| Boiling Point | 578.0±35.0°C at 760 mmHg |
| Melting Point | 259-260°C (methanol) |
| Density | 1.1±0.1 g/cm3 |
Reference Reading
1. Macrophage migration inhibitory factor (MIF) enhances hypochlorous acid production in phagocytic neutrophils
Lisa Schindler, Leon C D Smyth, Jürgen Bernhagen, Mark B Hampton, Nina Dickerhof Redox Biol. 2021 May;41:101946. doi: 10.1016/j.redox.2021.101946. Epub 2021 Mar 30.
Background: Macrophage migration inhibitory factor (MIF) is an important immuno-regulatory cytokine and is elevated in inflammatory conditions. Neutrophils are the first immune cells to migrate to sites of infection and inflammation, where they generate, among other mediators, the potent oxidant hypochlorous acid (HOCl). Here, we investigated the impact of MIF on HOCl production in neutrophils in response to phagocytic stimuli. Methods: Production of HOCl during phagocytosis of zymosan was determined using the specific fluorescent probe R19-S in combination with flow cytometry and live cell microscopy. The rate of phagocytosis was monitored using fluorescently-labeled zymosan. Alternatively, HOCl production was assessed during phagocytosis of Pseudomonas aeruginosa by measuring the oxidation of bacterial glutathione to the HOCl-specific product glutathione sulfonamide. Formation of neutrophil extracellular traps (NETs), an oxidant-dependent process, was quantified using a SYTOX Green plate assay. Results: Exposure of human neutrophils to MIF doubled the proportion of neutrophils producing HOCl during early stages of zymosan phagocytosis, and the concentration of HOCl produced was greater. During phagocytosis of P. aeruginosa, a greater fraction of bacterial glutathione was oxidized to glutathione sulfonamide in MIF-treated compared to control neutrophils. The ability of MIF to increase neutrophil HOCl production was independent of the rate of phagocytosis and could be blocked by the MIF inhibitor 4-IPP. Neutrophils pre-treated with MIF produced more NETs than control cells in response to PMA. Conclusion: Our results suggest a role for MIF in potentiating HOCl production in neutrophils in response to phagocytic stimuli. We propose that this newly discovered activity of MIF contributes to its role in mediating the inflammatory response and enhances host defence.
2. Scylla, Charybdis, and navigating antimicrobial action in the neutrophil phagosome
William M Nauseef J Leukoc Biol. 2022 Oct;112(4):587-589. doi: 10.1002/JLB.4CE0422-232R. Epub 2022 Aug 4.
The text extracted from the initial paragraph of a paper coauthored by Zanvil Cohn, one of the pioneers in the study of leukocyte biology, highlights two phenomena that stimulated investigations of innate immunity in the middle of the last century, namely phagocytosis and intracellular antimicrobial activity. Although many features of phagocytosis have been characterized since that time, fundamental aspects of the antimicrobial action of neutrophils remain unknown. The report by Ashby et al. provides a refined and nuanced look at the interface between an ingested microbe, Staphylococcus aureus, and HOCl generated by the myeloperoxidase (MPO)-H2 O2 -chloride system in neutrophil phagosomes and represents a holistic approach to the analysis of bactericidal mechanisms that recognizes contributions from both phagocyte and its ingested prey.
3. Effects of Polyphosphate on Leukocyte Function
Patrick M Suess Prog Mol Subcell Biol. 2022;61:131-143. doi: 10.1007/978-3-031-01237-2_6.
Leukocytes are immune cells derived from hematopoietic stem cells of the bone marrow which play essential roles in inflammatory and immune responses. In contrast to anucleate platelets and erythrocytes, leukocytes are differentiated from other blood cells by the presence of a nucleus, and consist of monocytes, neutrophils, lymphocytes, basophils, and eosinophils. Factors released from platelets mediate immune responses in part by recruitment and regulation of leukocyte activity. Platelet dense granules contain the highly anionic polymer polyphosphate (polyP) with monomer chain lengths of approximately 60-100 phosphates long, which are released into the microenvironment upon platelet activation. Recent studies suggest that polyP released from platelets plays roles in leukocyte migration, recruitment, accumulation, differentiation, and activation. Furthermore, bacterial-derived polyphosphate, generally consisting of phosphate monomer lengths in the hundreds to thousands, appear to play a role in pathogenic evasion of the host immune response. This review will discuss the effects of host and pathogenic-derived polyphosphate on leukocyte function.
Recommended Products
| BBF-00764 | Cerebroside C | Inquiry |
| BBF-05862 | Epirubicin | Inquiry |
| BBF-01825 | Loganin | Inquiry |
| BBF-03755 | Actinomycin D | Inquiry |
| BBF-01826 | Deoxymannojirimycin | Inquiry |
| BBF-02614 | Nystatin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
